Facebook
X
LinkedIn
Forward
19th Annual Advances in Neurology Symposium - September 11-12, 2026
In-Person and Virtual attendance options are available.
Presented by the Houston Methodist Neurological Institute
Overview
Neurology continues to advance rapidly through innovations in artificial intelligence, precision diagnostics, and emerging therapeutics. The 19th Annual Advances in Neurology Symposium will provide an evidence-based review of current developments across multiple neurological subspecialties, including stroke, neurodegenerative diseases, movement disorders, neuroimmunology, neuromuscular medicine, neurocritical care, and dementia.
Through expert-led presentations and discussion of cutting-edge research, participants will gain practical insights into the diagnosis and management of neurological disorders while exploring the expanding role of artificial intelligence, digital health, and other innovative technologies in enhancing clinical decision-making, optimizing workflows, and improving patient outcomes.
FEES
| REGISTRATION TYPE | FEE |
| Private physicians located within the Greater Houston Area | $520* |
| Private physicians located within the Greater Houston Area that do not want CME-Virtual Only | Complimentary Click here to register |
All others. Includes: | Complimentary |
*In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.
Presenters, topics, program schedule, and credit is subject to change
Target Audience
This conference is designed for physicians, nurses, nurse practitioners, physician assistants, physical therapists, occupational therapists, speech-language therapists and residents/fellows in the neurological sciences will benefit from this course.
Learning Objectives
By the end of this symposium, participants will be able to:
- Review current evidence-based approaches and emerging therapies for the diagnosis and management of neurological disorders across multiple subspecialties.
- Evaluate the applications, benefits, and limitations of artificial intelligence, digital health tools, and other innovative technologies in neurological practice.
- Apply recent advances in clinical research, precision diagnostics, and therapeutic strategies to improve patient outcomes in cerebrovascular, neurodegenerative, neuroimmunologic, and neuromuscular diseases.
- Assess the current state and anticipated future developments of AI-assisted tools in neurology, and identify opportunities to incorporate these innovations into clinical workflows to enhance diagnostic accuracy, efficiency, and personalized care.
| 19th Annual Advances in Neurology Symposium September 11-12, 2026 | ||
| Friday, September 11, 2026 | ||
| Time | Topic | Speaker(s) |
| 7:00 AM | Registration and Breakfast | |
| 8:00 AM | Welcome and Introductions | Rajan R. Gadhia, MD Eugene C. Lai, MD, PhD |
| 8:05 AM | Information and Decision Making in Neurology: From Paper to Digital to AI | Joseph P. Broderick, MD |
| 8:55 AM | Question and Answer Discussion | |
| 9:00 AM | The Role of Neuroinflammation in Neurodegenerative Diseases: Advances in How to Measure and How to Treat | Stanley H. Appel, MD |
| 9:50 AM | Question and Answer Discussion | |
| 9:55 AM | Break and Exhibits | |
| 10:15 AM | Machine Learning in Neuromuscular Disease Diagnosis: Reducing Delays or Reinforcing Bias? | Jun Li, MD, PhD, FANA, FAAN |
| 11:05 AM | Question and Answer Discussion | |
| 11:10 AM | AI‑Driven Phenotyping in Parkinson’s Disease: Promise, Pitfalls, and Clinical Reality | Andrew Billnitzer, MD, MPH |
| 12:00 PM | Question and Answer Discussion | |
| 12:05 PM | Lunch and Exhibits | |
| 1:05 PM | Announcements and Introductions | Rajan R. Gadhia, MD Eugene C. Lai, MD, PhD |
| 1:10 PM | AI‑Assisted Cognitive Assessment in Clinical Practice: Replacing, Refining, or Confusing the Neurologist? | Kenneth Podell, PhD, FACPN |
| 2:00 PM | Question and Answer Discussion | |
| 2:05 PM | Predictive Models in Neuroimmunology: Can AI Guide Therapy Selection Safely? | John A. Lincoln, MD, PhD |
| 2:55 PM | Question and Answer Discussion | |
| 3:00 PM | Break and Exhibits | |
| 3:20 PM | Predictive Analytics in Secondary Stroke Prevention: Are We Ready for AI Risk Stratification? | Farhaan S. Vahidy, PhD MBBS MPH FAHA |
| 4:10 PM | Question and Answer Discussion | |
| 4:15 PM | Artificial Intelligence in Dementia Diagnosis: Early Detection or Overdiagnosis? | Joseph C. Masdeu, MD, PhD |
| 5:05 PM | Question and Answer Discussion | |
| 5:10 PM | Adjournment | |
| Saturday, September 12, 2026 | ||
| Time | Topic | Speaker(s) |
| 7:00 AM | Registration and Breakfast | |
| 8:00 AM | Welcome and Introductions | Rajan R. Gadhia, MD Eugene C. Lai, MD, PhD |
| 8:05 AM | Novel Models for Diagnosis, Evaluation and Management of Acute Vision Loss. | Andrew Lee, MD |
| 8:55 AM | Question and Answer Discussion | |
| 9:00 AM | Innovative Advances in Diagnosis and Therapeutic Management of Atypical Central Demyelinating Syndromes | Abdul R. Alchaki, MD |
| 9:50 AM | Question and Answer Discussion | |
| 9:55 AM | Break and Exhibits | |
| 10:15 AM | Advances in Neurobiological Mechanisms in Traumatic Brain Injury | Ayush Batra, MD |
| 11:05 AM | Question and Answer Discussion | |
| 11:10 AM | Continuous EEG and multimodality monitoring into the next decade | Amit Verma, MD |
| 12:00 PM | Question and Answer Discussion | |
| 12:05 PM | Lunch and Exhibits | |
| 1:05 PM | Announcements and Introductions | Rajan R. Gadhia, MD Eugene C. Lai, MD, PhD |
| 1:10 PM | Novel Advances in Neurosurgical Management of Stroke – 2026 and Beyond | Tarun Bhalla, MD |
| 2:00 PM | Question and Answer Discussion | |
| 2:05 PM | Advances in Evaluation of Cerebral Venous Sinus Thrombosis | Riya Bhavsar, MD |
| 2:55 PM | Question and Answer Discussion | |
| 3:00 PM | Break and Exhibits | |
| 3:20 PM | Advances in Pediatric management of Epilepsy | Gretchen Von Allmen, MD |
| 4:10 PM | Question and Answer Discussion | |
| 4:15 PM | Wearables, Computer Vision, and AI in Movement Disorders: How Much Data Is Too Much? | Joseph Imbs, MD |
| 5:05 PM | Question and Answer Discussion | |
| 5:10 PM | Adjournment | |
In-Person attendance will be held in the Houston Methodist Research Institute (6670 Bertner Avenue, Houston, Texas 77030).
Virtual information will be provided to registered learners.
| COURSE DIRECTORS |
| Rajan R. Gadhia, MD |
| Vascular Neurologist Associate Professor of Clinical Neurology, Houston Methodist Academic Institute Associate Clinical Member, Houston Methodist Research Institute PD Vascular Neurology Fellowship Program; APD Neurology Residency Medical Director, HM Acute TeleNeurology, HM Concussion Center Eddy Scurlock Stroke Center Stanley H. Appel Department of Neurology Weill Cornell Medical College |
| Eugene C. Lai, MD, PhD |
| Robert W. Hervey Distinguished Endowed Chair for Parkinson’s Disease Research and Treatment Professor of Neurology and Neuroscience Stanley H. Appel Department of Neurology Houston Methodist |
Available Credit
- 14.75 AMA PRA Category 1 Credit™
Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Houston Methodist designates this Live activity for a maximum of 14.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 14.75 Attendance
- 14.75 Nursing Contact Hours
Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Houston Methodist will award up to 14.75 nursing professional development contact hours for this activity.
Interested in exhibiting? Contact us for more information.
Exhibitors
We gratefully acknowledge the following companies for participating as exhibitors for this activity:
Amgen
Amicus Therapeutics
Amneal Pharmaceuticals
Argenx
Averitas
Catalyst
Encompass Health
ITF Therapeutics
IV Solutions
Johnson & Johnson
KabaFusion
Merz
Novartis
Otsuka
Pfizer
Shionogi
SpringWorks
TG Therapeutics
Price
FEES
| REGISTRATION TYPE | FEE |
| Private physicians located within the Greater Houston Area | $520* |
| Private physicians located within the Greater Houston Area that do not want CME-Virtual Only | Complimentary Click here to register |
All others. Includes: | Complimentary |
*In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.